Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | SCN1A | P35498 | 1/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6400461 | 0.86 | ALDH1A1 (0.46) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL6402887 | 0.85 | ALDH1A1 (0.48) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL6405697 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL28994387 | 0.84 | ALDH1A1 (0.62) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL7865741 | 0.84 | ALDH1A1 (0.64) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL6399152 | 0.83 | ALDH1A1 (0.46) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL6402917 | 0.83 | ALDH1A1 (0.52) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL28994535 | 0.82 | ALDH1A1 (0.67) | ALDH1A1SCN1ASCN2ASCN3ATSHR | |
| SCHEMBL6398708 | 0.81 | ALDH1A1 (0.56) | ALDH1A1TSHRKMT2AKDM4E | |
| SCHEMBL3426363 | 0.78 | EGFR (0.48) | ALDH1A1TSHRALOX15KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050038283-A1 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | NEW JAPAN CHEMICAL, CO., LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
| EP-1227078-A1 | DICARBOXYLIC DIESTER, PROCESS FOR PRODUCING THE SAME, AND REFRIGERATING MACHINE LUBRICATING OIL COMPRISING THE ESTER | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2002-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038283-A1 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | SCO2, PDHX, DECR2 | ALDH1A1 3078/4885SCN1A 3770/4885SCN2A 3734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.